Metabolic Autopsy May Explain Some SIDS Cases

By HospiMedica staff writers
Posted on 26 Jul 2001
Metabolic autopsy using tandem mass spectrometry (MS/MS) may explain some sudden infant death syndrome (SIDS) cases, according to a study published in the July 2001 issue of Clinical Chemistry.

Researchers obtained postmortemn blood specimens from 7,058 infants and used MS/MS to obtain acylcarnitine and amino acid profiles. Specialized interpretation was used to evaluate profiles for disorders of fatty acid, organic acid, and amino acid metabolism. The analyses were compared with the analyses of bile specimens, newborn blood specimens, and specimens obtained from older infants at risk for metabolic disorders.

Results on 66 specimens suggested diagnoses of metabolic disorders. The researchers, from Neo Gen Screening (Bridgeville, PA, USA; www.neogenscreening), point out that without postmorten examination with MS/MS, the deaths from inherited metabolic disorders would have remained undiagnosed. This examination would not only provide a family with a plausible cause of their infant's death but could also serve to prevent morbidity and mortality in asymptomatic but affected siblings. Therefore, the researchers urge medical examiners and pathologists to consider an MS/MS analysis in all cases of infant deaths that are unexpected or of unknown cause.




Related Links:
Neo Gen Screening
Clinical Chemistry

Latest Critical Care News